ADCs: Toxin delivery to tumor cells versus not target cells based on Kd, target receptor expression and target receptor internalization
Bi-specifics: Receptor cross linking and downstream activation
Target mediated drug disposition (TMDD): Translation of PK from animal to human and the consequence of TMDD on dose and regimen
IgG1 mAbs: Improvment of effect duration through Fc engineering or pH dependent target binding